INTRODUCTIONPyoderma gangrenosum (PG) is a rare, neutrophilic dermatosis characterized by rapidly enlarging, painful ulcers with violaceous and undermined borders. It is commonly associated with systemic disorders, including rheumatoid arthritis, hematologic…
Read More
INTRODUCTIONAcne vulgaris (Acne) is a prevalent inflammatory skin condition that can cause lifelong physical consequences, including dyschromia and scars, leading to social and psychological impacts.1-3 While commonly associated with adolescence,…
Read More
INTRODUCTIONDermatology providers have traditionally used a test dose (TD) of methotrexate when initiating treatment to assess a patient's predisposition to severe adverse events, particularly myelosuppression.1 Although not standardized, a TD…
Read More
INTRODUCTIONFlap Design and Movement When linear closure along the resting skin tension lines (RSTL) is inappropriate for a given defect, other repairs may be considered. Rotation flaps can be a…
Read More
In this issue:VEHICLES MATTERAlthough data suggest that antibiotic use by dermatologists is decreasing, our specialty still has the highest rates of oral antibiotic prescribing across all fields of medicine.1,2 In…
Read More
Although data suggest that antibiotic use by dermatologists is decreasing, our specialty still has the highest rates of oral antibiotic prescribing across all fields of medicine.1,2 In an era of…
Read More
INTRODUCTIONAntibiotics are among the most frequently prescribed medications in clinical medicine and have long been central to dermatologic practice, particularly for the management of chronic inflammatory conditions such as acne…
Read More
INTRODUCTIONAtherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality worldwide and demands early identification and tailored risk reduction strategies.1 Randomized controlled trials have established the efficacy of…
Read More
INTRODUCTIONRoflumilast is a topical phosphodiesterase-4 inhibitor (PDE-4i) approved by the Food and Drug Administration (FDA) for treating dermatological conditions, including plaque psoriasis and atopic dermatitis. The 0.15% formulation was approved…
Read More
INTRODUCTIONMohs micrographic surgery (MMS) has emerged as a highly effective and precise treatment for skin cancer, offering exceptional cure rates while preserving healthy tissue.1 MMS involves the sequential removal of…
Read More
INTRODUCTIONSun exposure is a risk factor for melanoma and non-melanoma skin cancer (NMSC),1,2 with NMSC being the cause of most skin cancer-related deaths.3 In addition, sun exposure contributes to photoaging,…
Read More
INTRODUCTIONHair loss is a common dermatologic condition associated with significant psychosocial distress.1 It has been estimated that 50% of men and women suffer from the most common form of hair…
Read More
